Class II ยท Moderate risk
hydrALAZINE HCl Tablet
Labeling: Label Mixup; hydrALAZINE HCl Tablet, 50 mg may be potentially mislabeled as CapsuleTOPRIL, Tablet, 12.5 mg, NDC 00143117101, Pedigree: AD52778_16, EXP: 5/20/2014.
National Drug Code
Is NDC 50111-0328-01 recalled?
Hydralazine Hydrochloride · 100 TABLET in 1 BOTTLE (50111-328-01)
Yes — this exact package was recalled
1 FDA recall names the code 50111-0328-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Hydralazine Hydrochloride
- Strength
- HYDRALAZINE HYDROCHLORIDE 50 mg/1
- Form
- Tablet · Oral
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Type
- Human Prescription Drug
- Product code
- 50111-0328
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 50111-0433 See recall 2
- 50111-0647 Fluoxetine 2
- 50111-0648 Fluoxetine 2
- 50111-0327 Hydralazine Hydrochloride 1
- 50111-0441 See recall 1
- 50111-0467 See recall 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.